Cargando…
SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples
BACKGROUND: Given the persistence of viral RNA in clinically recovered coronavirus disease 2019 (COVID-19) patients, subgenomic RNAs (sgRNAs) have been reported as potential molecular viability markers for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, few data are available...
Autores principales: | Verma, Renu, Kim, Eugene, Martínez-Colón, Giovanny Joel, Jagannathan, Prasanna, Rustagi, Arjun, Parsonnet, Julie, Bonilla, Hector, Khosla, Chaitan, Holubar, Marisa, Subramanian, Aruna, Singh, Upinder, Maldonado, Yvonne, Blish, Catherine A, Andrews, Jason R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291522/ https://www.ncbi.nlm.nih.gov/pubmed/34295944 http://dx.doi.org/10.1093/ofid/ofab310 |
Ejemplares similares
-
Challenges in Harnessing Shared Within-Host Severe Acute Respiratory Syndrome Coronavirus 2 Variation for Transmission Inference
por: Walter, Katharine S, et al.
Publicado: (2023) -
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
por: Holubar, Marisa, et al.
Publicado: (2022) -
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
por: Hu, Zicheng, et al.
Publicado: (2022) -
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
por: Jagannathan, Prasanna, et al.
Publicado: (2021) -
Inflammatory but not respiratory symptoms are associated with ongoing upper airway viral shedding in outpatients with uncomplicated COVID-19
por: Jacobson, Karen B., et al.
Publicado: (2022)